Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 332

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 1
Chunk 332
---
 other public companies difficult or impossible.

If
we fail to maintain compliance with Nasdaq Listing Rules, our shares may be delisted from Nasdaq, which would result in a limited trading
market for our shares and make obtaining future debt or equity financing more difficult for the Company.

Our
common stock is listed on the Nasdaq Capital Market under the symbol “TELO”. However, there is no assurance that we will
be able to continue to maintain our compliance with the Nasdaq continued listing requirements. If we fail to do so, our securities may
be de-listed and cease trading on Nasdaq. As a result, selling our securities could be more difficult because smaller quantities of shares
or warrants would likely be bought and sold, transactions could be delayed, and security analysts’ coverage of us may be reduced.
In addition, in the event our securities are delisted, broker-dealers would face certain regulatory requirements which may discourage
them from effecting transactions in the securities and further limit the liquidity of the securities. These factors could result in lower
prices and larger spreads in the bid and ask prices for the securities. Such delisting from Nasdaq and continued or further declines
in the share price of the securities could also greatly impair our ability to raise additional necessary capital through equity or debt
financing and could significantly increase the ownership dilution to shareholders caused by our issuing equity in financing or other
transactions.

42

If
our shares were to be delisted from Nasdaq, they may become subject to the SEC’s “penny stock” rules.

Delisting
from Nasdaq may cause the securities of the Company to become subject to the SEC’s “penny stock” rules. The SEC generally
defines a penny stock as an equity security that has a market price of less than $5.00 per share or an exercise price of less than $5.00
per share, and that is not listed on a national securities exchange, such as Nasdaq subject to certain exemptions. Therefore, if shares
of our common stock were to be delisted from Nasdaq, the securities of the Company could become subject to the SEC’s “penny
stock” rules. These rules require, among other things, that any broker engaging in a purchase or sale of our securities provide
its customers with: (i) a risk disclosure document, (ii) disclosure of market quotations, if any, (iii) disclosure of the compensation
of the broker and its salespersons in the transaction, and (iv) monthly account